COMMUNIQUÉS West-GlobeNewswire

FDA Lifts Clinical Hold so MYC Inhibitor APTO-253 Can Return to Phase 1b Trial In Patients With Hematologic Cancers

29/06/2018 - 13:00

SAN DIEGO and TORONTO, June 29, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ:APTO) (TSX:APS) today announced that the U.S. Food and Drug Administration (FDA) has notified the company that it has lifted the [...]

RavenQuest Announces Media and Investor Open House at Edmonton Facility

29/06/2018 - 12:00

VANCOUVER, British Columbia, June 29, 2018 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (CSE:RQB) (OTCQB:RVVQF) (Frankfurt:1IT) (the “ Company ” or “ RavenQuest ”) is pleased to announce it will hold a media and investor [...]

Sanofi: Availability of the Pre-quarterly Results Communication

29/06/2018 - 08:01

Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Availability of the Pre-quarterly Results Communication Paris, France - June 29, 2018 - Sanofi announced today that its Pre-Quarterly Results Communication [...]

Sanofi : Mise en ligne du document «Pre-quarterly Results Communication »

29/06/2018 - 08:01

Communiqué de presse Source : Sanofi (EURONEXT: SAN) (NYSE: SNY) Mise en ligne du document «Pre-quarterly Results Communication » Paris, France - Le 29 juin 2018 - Sanofi annonce la mise en ligne sur l'espace [...]

Shire plc : Rule 2.9 Announcement

29/06/2018 - 08:01

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 29 June 2018 Shire [...]

Chi-Med to Announce 2018 Half-Year Financial Results

29/06/2018 - 08:00

LONDON, June 29, 2018 (GLOBE NEWSWIRE) -- Hutchison China MediTech Limited (“Chi-Med”) (AIM:HCM) (Nasdaq:HCM) will be announcing its interim results for the six months ended June 30, 2018 on Friday, July 27, 2018 at 7: [...]

Dividend payment ex-date of AS “Olainfarm”

29/06/2018 - 08:00

Dividend payment ex-date of AS “Olainfarm” AS “Olainfarm” (OLF1R, ISIN code LV0000100501) will close the list of shareholders for dividend payment on July 4, 2018 at the end of the working day of the Nasdaq CSD Latvian [...]

NICOX : Point sur les récents progrès de ses programmes et activités clés

29/06/2018 - 07:31

Communiqué de presse Nicox : Point sur les récents progrès de ses programmes et activités clés ............................................. 29 juin 2018 - diffusion à 7h30 Sophia Antipolis, France Nicox S.A. (Euronext [...]

Nicox Highlights Recent Progress with Key Programs and Activities

29/06/2018 - 07:31

Press Release Nicox Highlights Recent Progress with Key Programs and Activities .............................................. June 29, 2018 - release at 7:30 am CET Sophia Antipolis, France Nicox SA (Euronext Paris: [...]

Sensorion Shows Protective Effect of SENS-401 in Hearing Loss Models

29/06/2018 - 07:30

MONTPELLIER, France, June 29, 2018 (GLOBE NEWSWIRE) -- Sensorion ( FR 0012596468 – ALSEN ), a biotech company specializing in the treatment of inner ear diseases , presented data showing that its clinical stage product- [...]

VALNEVA Announces Successful Outcome of its AGM and Renewal of the Term of Office of its Management Board Members

29/06/2018 - 07:01

Valneva Announces Successful Outcome of its AGM and Renewal of the Term of Office of its Management Board Members Lyon (France), June 29, 2018 - Valneva SE ("Valneva" or "the Company"), a fully integrated, commercial [...]

VALNEVA annonce le succès de son Assemblée Générale et le renouvellement des mandats de son directoire

29/06/2018 - 07:01

Valneva annonce le succès de son Assemblée Générale et le renouvellement des mandats de son directoire Lyon (France), June 29, 2018 - Valneva SE ("Valneva" ou "le Groupe"), société de biotechnologie dédiée au [...]

Sanofi: CHMP recommends approval of Cablivi(TM) (caplacizumab)

29/06/2018 - 07:01

Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) CHMP recommends approval of Cablivi(TM) (caplacizumab) First therapeutic to receive positive CHMP opinion for treatment of a rare blood disorder called acquired [...]

Sanofi : Le CHMP recommande l'approbation du Cablivi(TM) (caplacizumab)

29/06/2018 - 07:01

Communiqué de presse Source : Sanofi (EURONEXT : SAN) (NYSE : SNY) Le CHMP recommande l'approbation du Cablivi(TM) (caplacizumab) Premier agent thérapeutique à obtenir un avis favorable du CHMP pour le traitement d'un [...]

Novartis announces intention to seek shareholder approval for 100% spinoff of Alcon eye care devices business; initiates share buyback of up to USD 5 bn

29/06/2018 - 07:01

Alcon strategic review concludes that 100% spinoff in best interest of shareholders and consistent with the Novartis strategy of focusing as a medicines company Planned spinoff would create world leading eye care [...]

Novartis annonce son intention de solliciter l'approbation des actionnaires pour la scission à 100% d'Alcon, sa division de produits ophtalmologiques, et initie un rachat d'actions à hauteur d'USD ...

29/06/2018 - 07:01

L'examen stratégique d'Alcon conclut qu'une scission à 100% serait dans l'intérêt des actionnaires et en ligne avec la stratégie de Novartis visant à se concentrer sur son activité pharmaceutique La scission prévue [...]

Zomedica Announces Interim Closing and Extension of Its Private Offering of Common Shares

29/06/2018 - 02:57

ANN ARBOR, Mich., June 28, 2018 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (TSX-V:ZOM) (the “Company”), a veterinary diagnostic and pharmaceutical company, announced today that it has [...]

Precision Therapeutics Signs Definitive Merger Agreement with Helomics Holding Corporation

29/06/2018 - 01:00

MINNEAPOLIS, June 28, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ:AIPT) (“Precision” or “the Company”), a company focused on applying artificial intelligence to personalized medicine and drug discovery [...]

RavenQuest Announces Non-Brokered Private Placement

28/06/2018 - 23:41

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAWS VANCOUVER, British Columbia, June [...]